9,10-anthraquinone has been researched along with cytochrome c-t in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dhabi, NA; Arun, Y; Balachandran, C; Duraipandiyan, V; Emi, N; Ignacimuthu, S; Inaguma, Y; Okamoto, A; Perumal, PT; Yamamoto, N | 1 |
1 other study(ies) available for 9,10-anthraquinone and cytochrome c-t
| Article | Year |
|---|---|
In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytochromes c; G1 Phase; Hep G2 Cells; HL-60 Cells; Humans; K562 Cells; MCF-7 Cells; Mitochondria; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resting Phase, Cell Cycle; Signal Transduction; U937 Cells | 2016 |